Claris Biotherapeutics

Acquisition, funding and merger involving Claris Biotherapeutics.

• Claris Biotherapeutics has just announced a $57 Million fundraising (posted on January 9 2024).

View the org chart displaying its 5 main executives

Most searched biographies at Claris Biotherapeutics

• Clarke Atwell, Chief Executive Officer and Board Member
• Reza Dana, Director
• Henry Rath, Chief Business Officer

Create your alert
to follow the executive moves at Claris Biotherapeutics.

Claris Biotherapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Claris Biotherapeutics

Social media about Claris Biotherapeutics

• Claris Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Claris Biotherapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Clarke Atwell

Call Claris Biotherapeutics at +1 412...

View the org chart

Register to receive your alert

Report an error